IL17A and inflammatory bowel disease: showed that IL17RA genetic variants increased susceptibility to inflammatory bowel disease pathogenesis and demonstrated the cumulative risk of IL17RA variants with genes of the IL23/IL17 pathway in the development of CD [46].